Collagen cross-linking effect on progressive keratoconus in patients younger than 18 years of age: A clinical trial

BACKGROUND: Keratoconus is a bilateral non-inflammatory corneal disease. Collagen cross-linking (CXL) is a new treatment option for the disease that uses ultraviolet A light irradiation and riboflavin administration. The aim of this study is to evaluate the effect of CXL on corneal topographic and r...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Adv Biomed Res
Asıl Yazarlar: Peyman, Alireza, Kamali, Ali, Khushabi, Maral, Nasrollahi, Kobra, Kargar, Neda, Taghaodi, Maryam, Razmjoo, Hasan, Fazel, Farhad, Salesi, Asiyeh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Medknow Publications & Media Pvt Ltd 2015
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4685639/
https://ncbi.nlm.nih.gov/pubmed/26693470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2277-9175.170240
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller